7037-30-1 Usage
Uses
Used in Pharmaceutical Industry:
3-(1-Methyl-piperidin-4-yl)-propan-1-ol is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its unique structure and properties make it a valuable building block in the development of new drugs and medications.
Used in Chemical Research:
In the field of chemical research, 3-(1-Methyl-piperidin-4-yl)-propan-1-ol serves as a subject for studying the properties and behavior of piperidine derivatives. This can lead to a better understanding of their potential applications and interactions with other chemical entities.
Used in Material Science:
3-(1-Methyl-piperidin-4-yl)-propan-1-ol may be utilized in the development of new materials with specific properties, such as improved solubility or reactivity. Its incorporation into polymers or other materials could result in novel applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 7037-30-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,0,3 and 7 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 7037-30:
(6*7)+(5*0)+(4*3)+(3*7)+(2*3)+(1*0)=81
81 % 10 = 1
So 7037-30-1 is a valid CAS Registry Number.
InChI:InChI=1/C9H19NO/c1-3-9(11)8-4-6-10(2)7-5-8/h8-9,11H,3-7H2,1-2H3
7037-30-1Relevant articles and documents
Process for the preparation of substituted pyrimidine derivatives
-
Page/Page column 14, (2010/02/16)
The present invention is directed to processes for the preparation of substituted pyrimidine derivatives, useful as intermediates in the synthesis of histamine H4 receptor modulators, and to intermediates in H4 modulator synthesis.
[4-(Benzo[B]Thiophen-2-Yl) Pyrimidin-2-Yl]-Amine Derivatives As Ikk-Beta Inhibitors For The Treatment Of Cancer And Inflammatory Diseases
-
Page/Page column 6, (2009/01/20)
The present invention provides compounds of Formula I: useful in the treatment of cancer and inflammatory diseases.
Benzoimidazole compounds
-
Page/Page column 16-17, (2008/06/13)
Benzoimidazole compounds, compositions, and methods of using them in leukocyte recruitment inhibition, in modulating H4 receptor, and in treating conditions such as inflammation, H4 receptor-mediated conditions, and related conditions.
Imidazole compounds
-
Page/Page column 17, (2010/02/14)
Imidazole compounds, compositions, and methods of using them in leukocyte recruitment inhibition, in modulating H4 receptor expression, and in treating conditions such as inflammation, H4 receptor-mediated conditions, and related con